Raymond James & Associates’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-10,474
| Closed | -$379K | – | 3888 |
|
2023
Q1 | $379K | Buy |
+10,474
| New | +$379K | ﹤0.01% | 3062 |
|
2021
Q3 | – | Sell |
-9,755
| Closed | -$300K | – | 4041 |
|
2021
Q2 | $300K | Sell |
9,755
-4,281
| -31% | -$132K | ﹤0.01% | 3414 |
|
2021
Q1 | $367K | Sell |
14,036
-6,157
| -30% | -$161K | ﹤0.01% | 3208 |
|
2020
Q4 | $508K | Sell |
20,193
-274
| -1% | -$6.89K | ﹤0.01% | 2784 |
|
2020
Q3 | $427K | Buy |
20,467
+2,140
| +12% | +$44.6K | ﹤0.01% | 2733 |
|
2020
Q2 | $435K | Sell |
18,327
-5,862
| -24% | -$139K | ﹤0.01% | 2671 |
|
2020
Q1 | $435K | Buy |
24,189
+706
| +3% | +$12.7K | ﹤0.01% | 2501 |
|
2019
Q4 | $557K | Sell |
23,483
-27,926
| -54% | -$662K | ﹤0.01% | 2635 |
|
2019
Q3 | $1.41M | Buy |
51,409
+5,666
| +12% | +$156K | ﹤0.01% | 1974 |
|
2019
Q2 | $1.51M | Buy |
45,743
+2,271
| +5% | +$75.2K | ﹤0.01% | 1958 |
|
2019
Q1 | $1.52M | Sell |
43,472
-2,562
| -6% | -$89.8K | ﹤0.01% | 1943 |
|
2018
Q4 | $1.53M | Buy |
46,034
+36,942
| +406% | +$1.23M | ﹤0.01% | 1821 |
|
2018
Q3 | $458K | Sell |
9,092
-1,227
| -12% | -$61.8K | ﹤0.01% | 2756 |
|
2018
Q2 | $618K | Buy |
10,319
+1,557
| +18% | +$93.2K | ﹤0.01% | 2532 |
|
2018
Q1 | $401K | Buy |
8,762
+1,570
| +22% | +$71.9K | ﹤0.01% | 2695 |
|
2017
Q4 | $287K | Sell |
7,192
-2,262
| -24% | -$90.3K | ﹤0.01% | 2849 |
|
2017
Q3 | $378K | Buy |
9,454
+1,396
| +17% | +$55.8K | ﹤0.01% | 2631 |
|
2017
Q2 | $347K | Buy |
8,058
+151
| +2% | +$6.5K | ﹤0.01% | 2625 |
|
2017
Q1 | $247K | Sell |
7,907
-17,210
| -69% | -$538K | ﹤0.01% | 2798 |
|
2016
Q4 | $634K | Buy |
25,117
+3,823
| +18% | +$96.5K | ﹤0.01% | 2185 |
|
2016
Q3 | $527K | Buy |
21,294
+270
| +1% | +$6.68K | ﹤0.01% | 2247 |
|
2016
Q2 | $428K | Sell |
21,024
-5,487
| -21% | -$112K | ﹤0.01% | 2183 |
|
2016
Q1 | $404K | Buy |
26,511
+11,312
| +74% | +$172K | ﹤0.01% | 2161 |
|
2015
Q4 | $204K | Sell |
15,199
-25,042
| -62% | -$336K | ﹤0.01% | 2318 |
|
2015
Q3 | $565K | Buy |
+40,241
| New | +$565K | ﹤0.01% | 1873 |
|